Vertex Pharmaceuticals (VRTX) revenue breakdown
By product, Product revenues, net is the largest at 100% of fiscal 2025 revenue.
By region, United States is the largest at 63% of fiscal 2025 revenue; Total revenues outside of the United States grew fastest, 37% a year over 6 years.
Revenue by product
Fiscal years, as Vertex Pharmaceuticals reports them in its 10-K filings; fiscal 2025 total $12.0B.
| Products | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|
| Product revenues, net | — | — | — | — | — | — | — | $12.0B | 100% |
| Other revenues | — | — | — | — | — | — | — | $31M | 0% |
| TRIKAFTA/KAFTRIO | — | — | — | — | $7.7B | $8.9B | $10.2B | — | — |
| Other product revenues | — | — | — | — | $1.2B | $924M | $782M | — | — |
| Product revenues, net | — | — | — | $7.6B | — | — | — | — | — |
| Product revenues, net | $3.0B | $4.2B | $6.2B | — | — | — | — | — | — |
| Other revenues | $9M | $2M | $3M | — | — | — | — | — | — |
| Other revenues | — | — | — | $1M | — | — | — | — | — |
Revenue by region
Fiscal years, as Vertex Pharmaceuticals reports them in its 10-K filings; fiscal 2025 total $12.0B.
| Regions | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| United States | $2.4B | $3.1B | $4.8B | $5.7B | $6.0B | $6.7B | $7.5B | 63% |
| Total revenues outside of the United States | $683M | $1.1B | $1.4B | $3.2B | $3.8B | $4.3B | $4.5B | 37% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for VRTX.
Open VRTX in InvestinglyQuestions
Where does Vertex Pharmaceuticals make its money?
In fiscal 2025, by product: Product revenues, net $12.0B, Other revenues $31M.
From Vertex Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.